<?xml version="1.0" encoding="UTF-8"?>
<hmdb xmlns="http://www.hmdb.ca"> 
<metabolite>
  <version>4.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2020-02-27 20:29:35 UTC</update_date>
  <accession>HMDB0000158</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB0000647</accession>
    <accession>HMDB00158</accession>
    <accession>HMDB00647</accession>
  </secondary_accessions>
  <name>L-Tyrosine</name>
  <description>Tyrosine is an essential amino acid that readily passes the blood-brain barrier. Once in the brain, it is a precursor for the neurotransmitters dopamine, norepinephrine and epinephrine, better known as adrenalin. These neurotransmitters are an important part of the body's sympathetic nervous system, and their concentrations in the body and brain are directly dependent upon dietary tyrosine. Tyrosine is not found in large concentrations throughout the body, probably because it is rapidly metabolized. Folic acid, copper and vitamin C are cofactor nutrients of these reactions. Tyrosine is also the precursor for hormones, thyroid, catecholestrogens and the major human pigment, melanin. Tyrosine is an important amino acid in many proteins, peptides and even enkephalins, the body's natural pain reliever. Valine and other branched amino acids, and possibly tryptophan and phenylalanine may reduce tyrosine absorption. A number of genetic errors of tyrosine metabolism occur, such as hawkinsinuria and tyrosinemia I. Most common is the increased amount of tyrosine in the blood of premature infants, which is marked by decreased motor activity, lethargy and poor feeding. Infection and intellectual deficits may occur. Vitamin C supplements reverse the disease. Some adults also develop elevated tyrosine in their blood. This indicates a need for more vitamin C. More tyrosine is needed under stress, and tyrosine supplements prevent the stress-induced depletion of norepinephrine and can cure biochemical depression. However, tyrosine may not be good for psychosis. Many antipsychotic medications apparently function by inhibiting tyrosine metabolism. L-dopa, which is directly used in Parkinson's, is made from tyrosine. Tyrosine, the nutrient, can be used as an adjunct in the treatment of Parkinson's. Peripheral metabolism of tyrosine necessitates large doses of tyrosine, however, compared to L-dopa (http://www.dcnutrition.com).</description>
  <synonyms>
    <synonym>(-)-alpha-Amino-p-hydroxyhydrocinnamic acid</synonym>
    <synonym>(2S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid</synonym>
    <synonym>(S)-(-)-Tyrosine</synonym>
    <synonym>(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid</synonym>
    <synonym>(S)-3-(p-Hydroxyphenyl)alanine</synonym>
    <synonym>(S)-alpha-Amino-4-hydroxybenzenepropanoic acid</synonym>
    <synonym>(S)-Tyrosine</synonym>
    <synonym>4-Hydroxy-L-phenylalanine</synonym>
    <synonym>L-Tyrosin</synonym>
    <synonym>Tyr</synonym>
    <synonym>TYROSINE</synonym>
    <synonym>Y</synonym>
    <synonym>(-)-a-Amino-p-hydroxyhydrocinnamate</synonym>
    <synonym>(-)-a-Amino-p-hydroxyhydrocinnamic acid</synonym>
    <synonym>(-)-alpha-Amino-p-hydroxyhydrocinnamate</synonym>
    <synonym>(-)-Α-amino-p-hydroxyhydrocinnamate</synonym>
    <synonym>(-)-Α-amino-p-hydroxyhydrocinnamic acid</synonym>
    <synonym>(2S)-2-Amino-3-(4-hydroxyphenyl)propanoate</synonym>
    <synonym>(S)-2-Amino-3-(p-hydroxyphenyl)propionate</synonym>
    <synonym>(S)-a-Amino-4-hydroxybenzenepropanoate</synonym>
    <synonym>(S)-a-Amino-4-hydroxybenzenepropanoic acid</synonym>
    <synonym>(S)-alpha-Amino-4-hydroxybenzenepropanoate</synonym>
    <synonym>(S)-Α-amino-4-hydroxybenzenepropanoate</synonym>
    <synonym>(S)-Α-amino-4-hydroxybenzenepropanoic acid</synonym>
    <synonym>(S)-a-Amino-4-hydroxy-benzenepropanoate</synonym>
    <synonym>(S)-a-Amino-4-hydroxy-benzenepropanoic acid</synonym>
    <synonym>(S)-alpha-Amino-4-hydroxy-benzenepropanoate</synonym>
    <synonym>(S)-alpha-Amino-4-hydroxy-benzenepropanoic acid</synonym>
    <synonym>2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoate</synonym>
    <synonym>2-Amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-propanoic acid</synonym>
    <synonym>3-(4-Hydroxyphenyl)-L-alanine</synonym>
    <synonym>Benzenepropanoate</synonym>
    <synonym>Benzenepropanoic acid</synonym>
    <synonym>L-p-Tyrosine</synonym>
    <synonym>p-Tyrosine</synonym>
    <synonym>L Tyrosine</synonym>
    <synonym>Tyrosine, L-isomer</synonym>
    <synonym>Tyrosine, L isomer</synonym>
    <synonym>Para tyrosine</synonym>
    <synonym>Para-tyrosine</synonym>
  </synonyms>
  <chemical_formula>C9H11NO3</chemical_formula>
  <average_molecular_weight>181.1885</average_molecular_weight>
  <monisotopic_molecular_weight>181.073893223</monisotopic_molecular_weight>
  <iupac_name>(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid</iupac_name>
  <traditional_iupac>L-tyrosine</traditional_iupac>
  <cas_registry_number>60-18-4</cas_registry_number>
  <smiles>N[C@@H](CC1=CC=C(O)C=C1)C(O)=O</smiles>
  <inchi>InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1</inchi>
  <inchikey>OUYCCCASQSFEME-QMMMGPOBSA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct_parent>Tyrosine and derivatives</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic acids and derivatives</super_class>
    <class>Carboxylic acids and derivatives</class>
    <sub_class>Amino acids, peptides, and analogues</sub_class>
    <molecular_framework>Aromatic homomonocyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>1-hydroxy-2-unsubstituted benzenoids</alternative_parent>
      <alternative_parent>Amino acids</alternative_parent>
      <alternative_parent>Amphetamines and derivatives</alternative_parent>
      <alternative_parent>Aralkylamines</alternative_parent>
      <alternative_parent>Carbonyl compounds</alternative_parent>
      <alternative_parent>Carboxylic acids</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>L-alpha-amino acids</alternative_parent>
      <alternative_parent>Monoalkylamines</alternative_parent>
      <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
      <alternative_parent>Organopnictogen compounds</alternative_parent>
      <alternative_parent>Phenylalanine and derivatives</alternative_parent>
      <alternative_parent>Phenylpropanoic acids</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
      <substituent>3-phenylpropanoic-acid</substituent>
      <substituent>Alpha-amino acid</substituent>
      <substituent>Amine</substituent>
      <substituent>Amino acid</substituent>
      <substituent>Amphetamine or derivatives</substituent>
      <substituent>Aralkylamine</substituent>
      <substituent>Aromatic homomonocyclic compound</substituent>
      <substituent>Benzenoid</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxylic acid</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>L-alpha-amino acid</substituent>
      <substituent>Monocarboxylic acid or derivatives</substituent>
      <substituent>Monocyclic benzene moiety</substituent>
      <substituent>Organic nitrogen compound</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organonitrogen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Organopnictogen compound</substituent>
      <substituent>Phenol</substituent>
      <substituent>Phenylalanine or derivatives</substituent>
      <substituent>Primary aliphatic amine</substituent>
      <substituent>Primary amine</substituent>
      <substituent>Tyrosine or derivatives</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>Common amino acids</external_descriptor>
      <external_descriptor>L-alpha-amino acid</external_descriptor>
      <external_descriptor>erythrose 4-phosphate/phosphoenolpyruvate family amino acid</external_descriptor>
      <external_descriptor>proteinogenic amino acid</external_descriptor>
      <external_descriptor>tyrosine</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Physiological effect</term>
      <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Health effect</term>
          <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
          <parent_id>7693</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Observation</term>
              <definition>A short term health effect which reflects the reponse of the body to stimuli or is a symptom of a disease or condition; also includes health status which reflects stage in life.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Attachment loss</term>
                  <definition/>
                  <parent_id>7717</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Missing teeth</term>
                  <definition/>
                  <parent_id>7717</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Periodontal Probing Depth</term>
                  <definition/>
                  <parent_id>7717</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Health condition</term>
              <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Viral infection</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Epilepsy</term>
                  <definition>A brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Epileptic spasms</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Schizophrenia</term>
                  <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cachexia</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cardiac disorders</term>
                  <definition>Any disorder that affects the heart.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Myocardial infarction</term>
                      <definition>A disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area. (nci ctcae).</definition>
                      <parent_id>7698</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Mi</synonym>
                        <synonym>Ami</synonym>
                        <synonym>Acute myocardial infarction</synonym>
                        <synonym>Heart attack</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Endocrine disorders</term>
                  <definition>Any disorder that affects the endocrine system. it can be neoplastic (carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma) or non-neoplastic (such as diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hypothyroidism</term>
                      <definition>A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland. (nci ctcae).</definition>
                      <parent_id>7704</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Underactive thyroid</synonym>
                        <synonym>Low thyroid</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cancer</term>
                  <definition>A group of disorders characterized by the presense of malignant neoplasm.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Leukemia</term>
                      <definition>A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells. (do).</definition>
                      <parent_id>7696</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Leukaemia</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Route of exposure</term>
          <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Enteral</term>
              <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
              <parent_id>7743</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Ingestion</term>
                  <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                  <parent_id>7744</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Digestion</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Food</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Synthetic</term>
              <definition>A man-made product or sample in which a chemical can be found.</definition>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Personal care product</term>
                  <definition/>
                  <parent_id>7742</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Pcp</synonym>
                    <synonym>Toiletries</synonym>
                    <synonym>Toiletry</synonym>
                    <synonym>Personal hygiene</synonym>
                    <synonym>Beautification product</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological</term>
              <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Animal</term>
                  <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fauna</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Plant</term>
                  <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                    <synonym>Flora</synonym>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Poaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Gramineae</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Coffea</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Coffee bean</synonym>
                        <synonym>Coffee</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Fabaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Papilionoideae</synonym>
                        <synonym>Legume</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glycine max</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Soy</synonym>
                        <synonym>Soya</synonym>
                        <synonym>Soybean</synonym>
                        <synonym>Soya bean</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cucurbitaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cucurbits</synonym>
                        <synonym>Gourds</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Theobroma cacao</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Tissue and substructures</term>
              <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>All tissues</term>
                  <definition>All tissues in the body of the organism.</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Placenta</term>
                  <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Organ and components</term>
              <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Prostate</term>
                  <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Prostate gland</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Feces</term>
                  <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fecal</synonym>
                    <synonym>Stool</synonym>
                    <synonym>Faecal</synonym>
                    <synonym>Faeces</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Breast milk</term>
                  <definition>Portion of secreted substance produced by the mammary gland.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Sweat</term>
                  <definition>Secretion produced by a sweat gland.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cytoplasm</term>
                  <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cytoplasma</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Mitochondria</term>
                  <definition/>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Cell and elements</term>
              <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Extracellular</term>
                  <definition>The space external to the outermost structure of a cell.</definition>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Extracellular region</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Catecholamine Biosynthesis</term>
                      <definition> catecholamines are sympathomimetic hormones that are released by the adrenal glands in response to stress. they are part of the sympathetic nervous system.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Disulfiram Action Pathway</term>
                      <definition> with regards to cocaine addiction, cocaine inhibits dopamine reuptake by blocking dopamine transporter 1 (dat1). this increases dopamine concentrations in the synapse and dopamine binding to its receptors induces euphoria.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Phenylalanine and Tyrosine Metabolism</term>
                      <definition> once in the body, phenylalanine may follow any of three paths. it may be (1) incorporated into cellular proteins, (2) converted to phenylpyruvic acid, or (3) converted to tyrosine.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Thyroid hormone synthesis</term>
                      <definition> iodine is necessary for the production of t3 and t4. a deficiency of iodine leads to decreased production of t3 and t4, enlarges the thyroid tissue and will cause the disease known as goitre.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Transcription/Translation</term>
                      <definition> these 3 rna classes include messenger rnas (mrnas), transfer rnas (trnas) and ribosomal rnas (rrnas). mrnas are the genetic coding templates used by the translational machinery to determine the order of amino acids incorporated into an elongating polypeptide in the process of translation.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Tyrosine Metabolism</term>
                      <definition> half of the phenylalanine required goes into the production of tyrosine; if the diet is rich in tyrosine itself, the requirements for phenylalanine are reduced by about 50%. phenylalanine hydroxylase is a mixed-function oxygenase: one atom of oxygen is incorporated into water and the other into the hydroxyl of tyrosine.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Role</term>
      <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Biological role</term>
          <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Trace element</term>
              <definition>A chemical element that occurs in very small amounts in organisms and is essential for many physiological and biochemical processes.В .</definition>
              <parent_id>7672</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
                <synonym>Trace mineral</synonym>
                <synonym>Essential mineral</synonym>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Industrial application</term>
          <definition>The assumed function of a chemical utilized by human.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Personal care products</term>
              <definition>Cosmetics and personal hygene products in which a chemical was incorportaed during  the manufacturing process.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Food and nutrition</term>
              <definition>A chemical purpose related to manufacturing of food and nutrition products.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Nutritional supplement</term>
                  <definition/>
                  <parent_id>7687</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Nutraceutical</synonym>
                    <synonym>Dietary supplement</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Pharmaceutical industry</term>
              <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical</term>
                  <definition/>
                  <parent_id>7679</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>water_solubility</kind>
      <value>0.479 mg/mL</value>
      <source></source>
    </property>
    <property>
      <kind>logp</kind>
      <value>-2.26</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>melting_point</kind>
      <value>343 °C</value>
      <source></source>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-2.39</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>-1.37</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>7.67 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>-1.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>9.19</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>181.1885</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>181.073893223</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>N[C@@H](CC1=CC=C(O)C=C1)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C9H11NO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>OUYCCCASQSFEME-QMMMGPOBSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>83.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>47.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>18.01</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>974</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>1176</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1117</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1175</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4862</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4863</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4864</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4865</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::EiMs</type>
      <spectrum_id>1974</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>383</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>384</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>385</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>386</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>387</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>388</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1602</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1669</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>2619</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30212</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30317</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30318</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30319</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30614</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30740</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30773</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31030</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31031</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>37328</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>245</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>246</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>247</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3155</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3156</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3157</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3158</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3159</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3160</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3161</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3162</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3163</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3164</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3165</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3166</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3167</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3168</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3169</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3170</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3171</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3172</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3173</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3174</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3175</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3176</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Cytoplasm</cellular>
      <cellular>Extracellular</cellular>
      <cellular>Mitochondria</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Breast Milk</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Feces</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Sweat</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
      <tissue>All Tissues</tissue>
      <tissue>Placenta</tissue>
      <tissue>Prostate</tissue>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>Alkaptonuria</name>
        <smpdb_id>SMP00169</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Aromatic L-Aminoacid Decarboxylase Deficiency</name>
        <smpdb_id>SMP00170</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Catecholamine Biosynthesis</name>
        <smpdb_id>SMP00012</smpdb_id>
        <kegg_map_id>map00350</kegg_map_id>
      </pathway>
      <pathway>
        <name>Disulfiram Action Pathway</name>
        <smpdb_id>SMP00429</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Dopamine beta-hydroxylase deficiency</name>
        <smpdb_id>SMP00498</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Hawkinsinuria</name>
        <smpdb_id>SMP00190</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Monoamine oxidase-a deficiency (MAO-A)</name>
        <smpdb_id>SMP00533</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Phenylalanine and Tyrosine Metabolism</name>
        <smpdb_id>SMP00008</smpdb_id>
        <kegg_map_id>map00360</kegg_map_id>
      </pathway>
      <pathway>
        <name>Phenylketonuria</name>
        <smpdb_id>SMP00206</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Thyroid hormone synthesis</name>
        <smpdb_id>SMP00716</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Transcription/Translation</name>
        <smpdb_id>SMP00019</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Tyrosine hydroxylase deficiency</name>
        <smpdb_id>SMP00497</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Tyrosine Metabolism</name>
        <smpdb_id>SMP00006</smpdb_id>
        <kegg_map_id>map00350</kegg_map_id>
      </pathway>
      <pathway>
        <name>Tyrosinemia Type 2 (or Richner-Hanhart syndrome)</name>
        <smpdb_id>SMP00369</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Tyrosinemia Type 3 (TYRO3)</name>
        <smpdb_id>SMP00370</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Tyrosinemia Type I</name>
        <smpdb_id>SMP00218</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Tyrosinemia, transient, of the newborn</name>
        <smpdb_id>SMP00494</smpdb_id>
        <kegg_map_id/>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>54.5 +/- 9.7</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>143 +/- 35.3</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>32-124</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>29-135</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (1 - 3 months old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>24-105</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (3 months - 6 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>43-88</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (6 - 18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>59.0 (47.0-71.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.</reference_text>
          <pubmed_id>12297216</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>34-94</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, Iinuma K, Saheki T: Neonatal presentation of adult-onset type II citrullinemia. Hum Genet. 2001 Feb;108(2):87-90.</reference_text>
          <pubmed_id>11281457</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>81.9 (69.8-94)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex/>
      <subject_condition>Normal</subject_condition>
      <comment>Cord blood at birth. n=495</comment>
      <references>
        <reference>
          <reference_text>Herberth G, Offenberg K, Rolle-Kampczyk U, Bauer M, Otto W, Roder S, Grutzmann K, Sack U, Simon JC, Borte M, von Bergen M, Lehmann I: Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases. J Allergy Clin Immunol. 2015 Aug;136(2):495-7. doi: 10.1016/j.jaci.2015.01.022. Epub 2015 Mar 7.</reference_text>
          <pubmed_id>25754623</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>120.0 +/- 100.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 92. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>68.0 +/- 10.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 92. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>72.0 +/- 15.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 92. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>61.0 +/- 13.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 92. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>55 - 147</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Thodi G, Schulpis KH, Dotsikas Y, Pavlides C, Molou E, Chatzidaki M, Triantafylli O, Loukas YL: Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment. J Pediatr Endocrinol Metab. 2016 Jan;29(1):15-20. doi: 10.1515/jpem-2015-0132.</reference_text>
          <pubmed_id>26226126</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>55-147</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>46 +/- 8</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, Volume 3. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>65.1 +/- 2.55 </concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by HPLC</comment>
      <references>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>84.2 (67.5-109)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex/>
      <subject_condition>Normal</subject_condition>
      <comment>n=449. p=0.016 (vs. newborn)</comment>
      <references>
        <reference>
          <reference_text>Herberth G, Offenberg K, Rolle-Kampczyk U, Bauer M, Otto W, Roder S, Grutzmann K, Sack U, Simon JC, Borte M, von Bergen M, Lehmann I: Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases. J Allergy Clin Immunol. 2015 Aug;136(2):495-7. doi: 10.1016/j.jaci.2015.01.022. Epub 2015 Mar 7.</reference_text>
          <pubmed_id>25754623</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS and UPLC-MS</comment>
      <references>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>35.0-80.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>The reference range has been derived from internal data at Molecular You, in addition to this published reference: MedlinePlus (https://www.nlm.nih.gov/medlineplus/ency/article/003361.htm)</comment>
      <references>
        <reference>
          <reference_text>Molecular You: https://molecularyou.com</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>61 +/- 13</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, Volume 3. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>72 +/- 15</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, Volume 3. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>62.9 +/- 12.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Feve B, Colle R, Ripoll L, Walther B, Boursier-Neyret C, Werner E, Becquemont L, Chanson P: The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. PLoS One. 2017 Mar 9;12(3):e0173615. doi: 10.1371/journal.pone.0173615. eCollection 2017.</reference_text>
          <pubmed_id>28278231</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>60.8(48.3-71.9)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 uears old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>n=68</comment>
      <references>
        <reference>
          <reference_text>Semba RD, Shardell M, Trehan I, Moaddel R, Maleta KM, Ordiz MI, Kraemer K, Khadeer M, Ferrucci L, Manary MJ: Metabolic alterations in children with environmental enteric dysfunction. Sci Rep. 2016 Jun 13;6:28009. doi: 10.1038/srep28009.</reference_text>
          <pubmed_id>27294788</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>142.0 +/- 4.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Norrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, Botker HE, Schmitz O, Jorgensen JO, Christiansen JS, Moller N: Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006 Jul;260(1):11-21.</reference_text>
          <pubmed_id>16789974</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Breast Milk</biospecimen>
      <concentration_value>15.0 +/- 6.6</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Samples collected in the morning on day 90 postpartum. Metabolite was measured by using 1H NMR spectroscopy.</comment>
      <references>
        <reference>
          <reference_text>Smilowitz JT, O'Sullivan A, Barile D, German JB, Lonnerdal B, Slupsky CM: The human milk metabolome reveals diverse oligosaccharide profiles. J Nutr. 2013 Nov;143(11):1709-18. doi: 10.3945/jn.113.178772. Epub 2013 Sep 11.</reference_text>
          <pubmed_id>24027187</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>10.1 (6.37-13.8)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.</reference_text>
          <pubmed_id>12834252</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>12.0 +/- 9.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
          <pubmed_id>18502700</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>24.5 +/- 8.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
          <pubmed_id>15911239</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>6.4 +/- 1.5</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>9.3 +/- 2.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.</reference_text>
          <pubmed_id>6198473</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>7.9 +/- 3.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.</reference_text>
          <pubmed_id>6198473</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>12.2 +/- 3.8</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, Aziat F, Wishart DS: Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med. 2012 Apr 30;4(4):38.</reference_text>
          <pubmed_id>22546835</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>8.0 +/- 1.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>3.9-18.5</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (0 - 10 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>3.9-17</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adolescent (&gt;11 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013.</reference_text>
          <pubmed_id>24130822</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, Allen-Vercoe E, Aucoin MG: Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. J Proteome Res. 2015 Mar 6;14(3):1472-82. doi: 10.1021/pr5011247. Epub 2015 Feb 25.</reference_text>
          <pubmed_id>25670064</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P: Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009 Jul 28;4(7):e6386. doi: 10.1371/journal.pone.0006386.</reference_text>
          <pubmed_id>19636438</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS on lyophilized fecal samples from premature breast milk-fed infants</comment>
      <references>
        <reference>
          <reference_text>Poroyko V, Morowitz M, Bell T, Ulanov A, Wang M, Donovan S, Bao N, Gu S, Hong L, Alverdy JC, Bergelson J, Liu DC: Diet creates metabolic niches in the "immature gut" that shape microbial communities. Nutr Hosp. 2011 Nov-Dec;26(6):1283-95. doi: 10.1590/S0212-16112011000600015.</reference_text>
          <pubmed_id>22411374</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Children (6 - 18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>478.323 (294.353-662.294)</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Healthy infants (HC). The water-soluble fraction of the fecal samples was analyzed using SPME GC-MS and 1H NMR. These are the median values and ranges of concentration (ppm) of metabolite of the fecal samples. The original concentration was reported as 0.26 (0.16-0.36) ppm of wet feces.</comment>
      <references>
        <reference>
          <reference_text>Francavilla R, Calasso M, Calace L, Siragusa S, Ndagijimana M, Vernocchi P, Brunetti L, Mancino G, Tedeschi G, Guerzoni E, Indrio F, Laghi L, Miniello VL, Gobbetti M, De Angelis M: Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr Allergy Immunol. 2012 Aug;23(5):420-7. doi: 10.1111/j.1399-3038.2012.01286.x. Epub 2012 Mar 22.</reference_text>
          <pubmed_id>22435727</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>1048.632 (588.706-1508.558)</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Infants with cow's milk protein allergy infants who were fed diets without lactose (CMA-NL).  The water-soluble fraction of the fecal samples was analyzed using SPME GC-MS and 1H NMR. These are the median values and ranges of concentration (ppm) of metabolite of the fecal samples. The original concentration was reported as 0.57 (0.32-0.82) ppm of wet feces.</comment>
      <references>
        <reference>
          <reference_text>Francavilla R, Calasso M, Calace L, Siragusa S, Ndagijimana M, Vernocchi P, Brunetti L, Mancino G, Tedeschi G, Guerzoni E, Indrio F, Laghi L, Miniello VL, Gobbetti M, De Angelis M: Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr Allergy Immunol. 2012 Aug;23(5):420-7. doi: 10.1111/j.1399-3038.2012.01286.x. Epub 2012 Mar 22.</reference_text>
          <pubmed_id>22435727</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>1453.367 (607.103-2299.631)</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Infants with cow's milk protein allergy infants who were fed diets with lactose (CMA-L). The water-soluble fraction of the fecal samples was analyzed using SPME GC-MS and 1H NMR. These are the median values and ranges of concentration (ppm) of metabolite of the fecal samples. The original concentration was reported as 0.79 (0.33-1.25) ppm of wet feces.</comment>
      <references>
        <reference>
          <reference_text>Francavilla R, Calasso M, Calace L, Siragusa S, Ndagijimana M, Vernocchi P, Brunetti L, Mancino G, Tedeschi G, Guerzoni E, Indrio F, Laghi L, Miniello VL, Gobbetti M, De Angelis M: Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr Allergy Immunol. 2012 Aug;23(5):420-7. doi: 10.1111/j.1399-3038.2012.01286.x. Epub 2012 Mar 22.</reference_text>
          <pubmed_id>22435727</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P: Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009 Jul 28;4(7):e6386. doi: 10.1371/journal.pone.0006386.</reference_text>
          <pubmed_id>19636438</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By CIL LC−MS </comment>
      <references>
        <reference>
          <reference_text>Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, Li L: Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015 Jan 20;87(2):829-36. doi: 10.1021/ac503619q. Epub 2014 Dec 25.</reference_text>
          <pubmed_id>25486321</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Christopher W. ArmstrongNeil R. McGregorDonald P. LewisHenry L. ButtPaul R. Gooley. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics.  January 2017, 13:8: https://link.springer.com/article/10.1007/s11306-016-1145-z</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=9) were used in the study.  Instrument: 1H NMR . Technology specification: 600MHz 1D; 2D; TOCSY, HSQC NMR.</comment>
      <references>
        <reference>
          <reference_text>Lamichhane S, Yde CC, Schmedes MS, Jensen HM, Meier S, Bertram HC: Strategy for Nuclear-Magnetic-Resonance-Based Metabolomics of Human Feces. Anal Chem. 2015 Jun 16;87(12):5930-7. doi: 10.1021/acs.analchem.5b00977. Epub 2015 May 28.</reference_text>
          <pubmed_id>25985090</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>1H NMR on fecal extract</comment>
      <references>
        <reference>
          <reference_text>Saric J, Wang Y, Li J, Coen M, Utzinger J, Marchesi JR, Keiser J, Veselkov K, Lindon JC, Nicholson JK, Holmes E: Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res. 2008 Jan;7(1):352-60. Epub 2007 Dec 1.</reference_text>
          <pubmed_id>18052033</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-TOFMS on lyophilized fecal samples</comment>
      <references>
        <reference>
          <reference_text>Phua LC, Koh PK, Cheah PY, Ho HK, Chan EC: Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:103-13. doi: 10.1016/j.jchromb.2013.08.025. Epub 2013 Aug 26.</reference_text>
          <pubmed_id>24029555</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>700 +/- 420</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=12) were used in the study. Instrument: LC-MS. Technology specification: HPLC-MS/MS and DIMS/MS using Biocrates P-180 kit. The original concentration was reported as 0.7 +/- 0.42 umol/g of wet feces.</comment>
      <references>
        <reference>
          <reference_text>Turroni S, Fiori J, Rampelli S, Schnorr SL, Consolandi C, Barone M, Biagi E, Fanelli F, Mezzullo M, Crittenden AN, Henry AG, Brigidi P, Candela M: Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative view. Sci Rep. 2016 Sep 14;6:32826. doi: 10.1038/srep32826.</reference_text>
          <pubmed_id>27624970</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>GC MS on fecal extract</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL: Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem. 2009 Oct 15;393(2):163-75. doi: 10.1016/j.ab.2009.06.036. Epub 2009 Jun 30.</reference_text>
          <pubmed_id>19573517</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>110 +/- 100</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=17) were used in the study. Instrument: LC-MS. Technology specification: HPLC-MS/MS and DIMS/MS using Biocrates P-180 kit. The original concentration was reported as 0.11 +/- 0.1 umol/g of wet feces.</comment>
      <references>
        <reference>
          <reference_text>Turroni S, Fiori J, Rampelli S, Schnorr SL, Consolandi C, Barone M, Biagi E, Fanelli F, Mezzullo M, Crittenden AN, Henry AG, Brigidi P, Candela M: Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative view. Sci Rep. 2016 Sep 14;6:32826. doi: 10.1038/srep32826.</reference_text>
          <pubmed_id>27624970</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>2D NMR on fecal extracts</comment>
      <references>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>114.246 +/- 94.322</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC MS on fecal extract. The original unit of the concentration was reported as ug/mL. The concentration has been converted to nmol/g using the assumption that 1 mL = 1 g of feces.</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL: Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem. 2009 Oct 15;393(2):163-75. doi: 10.1016/j.ab.2009.06.036. Epub 2009 Jun 30.</reference_text>
          <pubmed_id>19573517</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By 1H NMR analysis of lyopholized fecal samples of infants from overweight and obese mothers.</comment>
      <references>
        <reference>
          <reference_text>Martin FP, Moco S, Montoliu I, Collino S, Da Silva L, Rezzi S, Prieto R, Kussmann M, Inostroza J, Steenhout P: Impact of breast-feeding and high- and low-protein formula on the metabolism and growth of infants from overweight and obese mothers. Pediatr Res. 2014 Apr;75(4):535-43. doi: 10.1038/pr.2013.250. Epub 2013 Dec 27.</reference_text>
          <pubmed_id>24375085</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal water. Metabolite detected using 1H NMR spectroscopy</comment>
      <references>
        <reference>
          <reference_text>Gratton J, Phetcharaburanin J, Mullish BH, Williams HR, Thursz M, Nicholson JK, Holmes E, Marchesi JR, Li JV: Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces. Anal Chem. 2016 May 3;88(9):4661-8. doi: 10.1021/acs.analchem.5b04159. Epub 2016  Apr 21.</reference_text>
          <pubmed_id>27065191</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Su X, Wang N, Chen D, Li Y, Lu Y, Huan T, Xu W, Li L, Li L: Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes. Anal Chim Acta. 2016 Jan 15;903:100-9. doi: 10.1016/j.aca.2015.11.027. Epub 2015  Nov 25.</reference_text>
          <pubmed_id>26709303</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>1H NMR on lyopholized feces</comment>
      <references>
        <reference>
          <reference_text>Jacobs DM, Deltimple N, van Velzen E, van Dorsten FA, Bingham M, Vaughan EE, van Duynhoven J: (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008 Jul;21(6):615-26.</reference_text>
          <pubmed_id>18085514</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
          <pubmed_id>27543620</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
      <references>
        <reference>
          <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
          <pubmed_id>29808030</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>GC-MS on fecal extract</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
          <pubmed_id>20669995</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>36.17 +/- 15.02</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>&gt;10</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.</reference_text>
          <pubmed_id>12097436</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>5 (&lt;1-78)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated non-smoker (n=23)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>1-77</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker (n=23)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>30 (&lt;1-91)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker and non-smoker (n=20)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>12 (&lt;1-49)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Unstimulated smoker and non-smoker (n=20)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>11.1 +/- 7.65</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Possive drool method (n=18)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>15.1 +/- 10.3</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Salivettes (n=18)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>1-127</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>normal</subject_condition>
      <comment>At rest without stimulation</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>1-68</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>normal</subject_condition>
      <comment>Salivary induction with a citric acid solution applied directly to the  tongue (stimulated)</comment>
      <references>
        <reference>
          <reference_text>Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C: Understanding the human salivary metabolome. NMR Biomed. 2009 Jul;22(6):577-84. doi: 10.1002/nbm.1369.</reference_text>
          <pubmed_id>19259987</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>13.7 +/- 3.6</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Before regular lecture</comment>
      <references>
        <reference>
          <reference_text>Nakamura Y, Kodama H, Satoh T, Adachi K, Watanabe S, Yokote Y, Sakagami H: Diurnal changes in salivary amino acid concentrations. In Vivo. 2010 Nov-Dec;24(6):837-42.</reference_text>
          <pubmed_id>21164041</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>12.0 +/- 5.8</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>After regular lecture</comment>
      <references>
        <reference>
          <reference_text>Nakamura Y, Kodama H, Satoh T, Adachi K, Watanabe S, Yokote Y, Sakagami H: Diurnal changes in salivary amino acid concentrations. In Vivo. 2010 Nov-Dec;24(6):837-42.</reference_text>
          <pubmed_id>21164041</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>11.8 +/- 6.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Before examination</comment>
      <references>
        <reference>
          <reference_text>Nakamura Y, Kodama H, Satoh T, Adachi K, Watanabe S, Yokote Y, Sakagami H: Diurnal changes in salivary amino acid concentrations. In Vivo. 2010 Nov-Dec;24(6):837-42.</reference_text>
          <pubmed_id>21164041</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Alvarez-Sanchez B, Priego-Capote F, Luque de Castro MD: Study of sample preparation for metabolomic profiling of human saliva by liquid chromatography-time of flight/mass spectrometry. J Chromatogr A. 2012 Jul 27;1248:178-81. doi: 10.1016/j.chroma.2012.05.029. Epub  2012 May 12.</reference_text>
          <pubmed_id>22727327</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>39.85 +/- 24.71</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>12.2 +/- 3.8</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>After examination</comment>
      <references>
        <reference>
          <reference_text>Nakamura Y, Kodama H, Satoh T, Adachi K, Watanabe S, Yokote Y, Sakagami H: Diurnal changes in salivary amino acid concentrations. In Vivo. 2010 Nov-Dec;24(6):837-42.</reference_text>
          <pubmed_id>21164041</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value>70-270</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (60 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Sweat (Forehead)</comment>
      <references>
        <reference>
          <reference_text>Kutyshenko VP, Molchanov M, Beskaravayny P, Uversky VN, Timchenko MA: Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS One. 2011;6(12):e28824. doi: 10.1371/journal.pone.0028824. Epub 2011 Dec 14.</reference_text>
          <pubmed_id>22194922</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value>40</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (40 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Sweat (Arms)</comment>
      <references>
        <reference>
          <reference_text>Kutyshenko VP, Molchanov M, Beskaravayny P, Uversky VN, Timchenko MA: Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS One. 2011;6(12):e28824. doi: 10.1371/journal.pone.0028824. Epub 2011 Dec 14.</reference_text>
          <pubmed_id>22194922</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult </subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Delgado-Povedano MM, Calderon-Santiago M, Priego-Capote F, Luque de Castro MD: Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode. Anal Chim Acta. 2016 Jan 28;905:115-25. doi: 10.1016/j.aca.2015.11.048. Epub 2015 Dec 17.</reference_text>
          <pubmed_id>26755145</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.1 (6.1-23.2)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>21.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guo K, Li L: Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem. 2009 May 15;81(10):3919-32. doi: 10.1021/ac900166a.</reference_text>
          <pubmed_id>19309105</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
          <pubmed_id>28157703</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>5.52-38.66</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>David F. Putnam Composition and Concentrative Properties of Human Urine. NASA Contractor Report. July 1971</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>4.3-9.2 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>9.5 (4.1-23.5)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.0 +/- 0.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By cation exchange chromatography</comment>
      <references>
        <reference>
          <reference_text>Parvy PR, Bardet JI, Rabier DM, Kamoun PP: Age-related reference values for free amino acids in first morning urine specimens. Clin Chem. 1988 Oct;34(10):2092-5.</reference_text>
          <pubmed_id>3168222</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.9 +/- 0.7</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (1 - 6 months old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By cation exchange chromatography. Samples were collected from infants of 1-6 months old</comment>
      <references>
        <reference>
          <reference_text>Parvy PR, Bardet JI, Rabier DM, Kamoun PP: Age-related reference values for free amino acids in first morning urine specimens. Clin Chem. 1988 Oct;34(10):2092-5.</reference_text>
          <pubmed_id>3168222</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.7 +/- 0.8</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (6 months - &lt;1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By cation exchange chromatography</comment>
      <references>
        <reference>
          <reference_text>Parvy PR, Bardet JI, Rabier DM, Kamoun PP: Age-related reference values for free amino acids in first morning urine specimens. Clin Chem. 1988 Oct;34(10):2092-5.</reference_text>
          <pubmed_id>3168222</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.72</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ.  Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy.  Metabolomics.  2009</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.0370-168.459</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Urine compound detected by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>After green tea sonsumption</comment>
      <references>
        <reference>
          <reference_text>Van Dorsten FA, Daykin CA, Mulder TP, Van Duynhoven JP: Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem. 2006 Sep 6;54(18):6929-38.</reference_text>
          <pubmed_id>16939360</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>After black tea sonsumption</comment>
      <references>
        <reference>
          <reference_text>Van Dorsten FA, Daykin CA, Mulder TP, Van Duynhoven JP: Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem. 2006 Sep 6;54(18):6929-38.</reference_text>
          <pubmed_id>16939360</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>14.588 +/- 10.744</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>27.35 +/- 13.98</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
          <pubmed_id>2026685</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7.41 +/- 2.30</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jones MG, Cooper E, Amjad S, Goodwin CS, Barron JL, Chalmers RA: Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta. 2005 Nov;361(1-2):150-8.</reference_text>
          <pubmed_id>15992788</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>8.7 (3.0-20.1)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>by LC-MS/MS (Biocrates kit)</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6-57</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC MS/MS</comment>
      <references>
        <reference>
          <reference_text>Casado M, Sierra C, Batllori M, Artuch R, Ormazabal A: A targeted metabolomic procedure for amino acid analysis in different biological specimens by ultra-high-performance liquid chromatography-tandem mass spectrometry. Metabolomics. 2018 May 25;14(6):76. doi: 10.1007/s11306-018-1374-4.</reference_text>
          <pubmed_id>30830347</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.72 (0.18-1.38)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>4.2 +/- 1.85</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>8.8 +/- 4.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7.0 +/- 3.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>42.96 +/- 27.13</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By Aminoacid autoanalyzer. The average gestational age is 32.2 weeks</comment>
      <references>
        <reference>
          <reference_text>Illsinger S, Schmidt KH, Lucke T, Vaske B, Bohnhorst B, Das AM: Plasma and urine amino acid pattern in preterm infants on enteral nutrition: impact of gestational age. Amino Acids. 2010 Mar;38(3):959-72. doi: 10.1007/s00726-009-0305-0. Epub 2009 May 26.</reference_text>
          <pubmed_id>19468821</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>66.71 +/- 47.49</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By Aminoacid autoanalyzer. The average gestational age is 30.7 weeks</comment>
      <references>
        <reference>
          <reference_text>Illsinger S, Schmidt KH, Lucke T, Vaske B, Bohnhorst B, Das AM: Plasma and urine amino acid pattern in preterm infants on enteral nutrition: impact of gestational age. Amino Acids. 2010 Mar;38(3):959-72. doi: 10.1007/s00726-009-0305-0. Epub 2009 May 26.</reference_text>
          <pubmed_id>19468821</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>70.10 +/- 45.22</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By Aminoacid autoanalyzer. The average gestational age is 25.7 weeks</comment>
      <references>
        <reference>
          <reference_text>Illsinger S, Schmidt KH, Lucke T, Vaske B, Bohnhorst B, Das AM: Plasma and urine amino acid pattern in preterm infants on enteral nutrition: impact of gestational age. Amino Acids. 2010 Mar;38(3):959-72. doi: 10.1007/s00726-009-0305-0. Epub 2009 May 26.</reference_text>
          <pubmed_id>19468821</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.22 - 67.72</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>13.79 - 63.88</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (1 - 6 months old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.1-11.1 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>12.55 - 66.48</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (6 months - &lt;1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.04 - 59.02</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 2 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.1-14.81</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>9.95 - 29.96</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (2 - 4 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>5.82 +/- 3.26</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.22 - 42.62</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (4 - 13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>5.96 +/- 2.98</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. Healthy and term-neonate’s urinary metabolites concentration values measured by targeted metabolomics (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.36 - 27.70</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adolescent (13 - 21 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.36 - 27.70</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;21 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By LC-MS/MS. Ranges are 2.5th-97.5th%iles.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Kvitvang HF, Andreassen T, Adam T, Villas-Boas SG, Bruheim P: Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids. Anal Chem. 2011 Apr 1;83(7):2705-11. doi: 10.1021/ac103245b. Epub 2011 Mar 9.</reference_text>
          <pubmed_id>21388201</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>10.9 (2.566-19.1)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>24.3893 +/- 10.0806</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By DI-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>With the consumption of cocoa powder and chocolate (solid or drink)</comment>
      <references>
        <reference>
          <reference_text>Llorach R, Urpi-Sarda M, Jauregui O, Monagas M, Andres-Lacueva C: An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. J Proteome Res. 2009 Nov;8(11):5060-8. doi: 10.1021/pr900470a.</reference_text>
          <pubmed_id>19754154</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>91.2 +/- 30.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <references>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>73.0 +/- 20.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <references>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Oesophageal cancer</patient_information>
      <comment>By NMR and LC-MS </comment>
      <references>
        <reference>
          <reference_text>Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, Raftery D: Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One. 2012;7(1):e30181. doi: 10.1371/journal.pone.0030181. Epub 2012 Jan 23.</reference_text>
          <pubmed_id>22291914</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>82.5 +/- 21.1</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Obesity</patient_information>
      <comment>with substantial overweight reduction. p=0.04 (vs. the group without substantial weight loss)</comment>
      <references>
        <reference>
          <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>91.7 +/- 19.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Obesity</patient_information>
      <comment>without substantial overweight reduction</comment>
      <references>
        <reference>
          <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>57.2 +/- 24.4</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart Transplant</patient_information>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>56.9 +/- 15.2 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
      <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>55.82 +/- 19.6 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>54.1 (15.3) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Early preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>58.0 (22.3) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>50.7 (46.8-54.6)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Epilepsy</patient_information>
      <comment> Acute seizures
</comment>
      <references>
        <reference>
          <reference_text>Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.</reference_text>
          <pubmed_id>14992292</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>74.0 (71.0-77.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Myocardial infarction</patient_information>
      <references>
        <reference>
          <reference_text>Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR: The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr. 1976 Sep;29(9):997-1006.</reference_text>
          <pubmed_id>822705</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>81.0 (75.9-86.1)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Epilepsy</patient_information>
      <comment> Refractory localization-related epilepsy (RLE)
</comment>
      <references>
        <reference>
          <reference_text>Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.</reference_text>
          <pubmed_id>14992292</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>90.0 (81.0-99.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Viral Infection</patient_information>
      <references>
        <reference>
          <reference_text>Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR: The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr. 1976 Sep;29(9):997-1006.</reference_text>
          <pubmed_id>822705</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>143-246</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Citrullinemia type II, neonatal-onset</patient_information>
      <references>
        <reference>
          <reference_text>Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, Iinuma K, Saheki T: Neonatal presentation of adult-onset type II citrullinemia. Hum Genet. 2001 Feb;108(2):87-90.</reference_text>
          <pubmed_id>11281457</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <references>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>257</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Fumaric aciduria</patient_information>
      <references>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1471.948</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Hereditary tyrosinemia</patient_information>
      <references>
        <reference>
          <reference_text>Swarna M, Jyothy A, Usha Rani P, Reddy PP: Amino acid disorders in mental retardation: a two-decade study from Andhra Pradesh. Biochem Genet. 2004 Apr;42(3-4):85-98.</reference_text>
          <pubmed_id>15168722</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&gt;220</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Tyrosinemia I</patient_information>
      <references>
        <reference>
          <reference_text>Nakamura K, Matsumoto S, Mitsubuchi H, Endo F: Diagnosis and treatment of hereditary tyrosinemia in Japan. Pediatr Int. 2015;57(1):37-40. doi: 10.1111/ped.12550.</reference_text>
          <pubmed_id>25443793</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>108-146</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>S-Adenosylhomocysteine hydrolase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Labrune P, Perignon JL, Rault M, Brunet C, Lutun H, Charpentier C, Saudubray JM, Odievre M: Familial hypermethioninemia partially responsive to dietary restriction. J Pediatr. 1990 Aug;117(2 Pt 1):220-6.</reference_text>
          <pubmed_id>2380820</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>310-1410</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Tyrosinemia I</patient_information>
      <comment>Plasma concentration range for patients non-compliant with treatment.</comment>
      <references>
        <reference>
          <reference_text>Gissen P, Preece MA, Willshaw HA, McKiernan PJ: Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC. J Inherit Metab Dis. 2003;26(1):13-6.</reference_text>
          <pubmed_id>12872835</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>395.1 - 586.7</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex/>
      <patient_information>Hawkinsinuria</patient_information>
      <references>
        <reference>
          <reference_text>Thodi G, Schulpis KH, Dotsikas Y, Pavlides C, Molou E, Chatzidaki M, Triantafylli O, Loukas YL: Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment. J Pediatr Endocrinol Metab. 2016 Jan;29(1):15-20. doi: 10.1515/jpem-2015-0132.</reference_text>
          <pubmed_id>26226126</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>48-95</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>S-Adenosylhomocysteine hydrolase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Labrune P, Perignon JL, Rault M, Brunet C, Lutun H, Charpentier C, Saudubray JM, Odievre M: Familial hypermethioninemia partially responsive to dietary restriction. J Pediatr. 1990 Aug;117(2 Pt 1):220-6.</reference_text>
          <pubmed_id>2380820</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>42.94 (11.38)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>45.63 (19.15)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>65.1 (23.7) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Late-onset preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>62.3 (21.7) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>By GC-MS and UPLC-MS</comment>
      <references>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>57.2 +/- 3.33</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by HPLC</comment>
      <references>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>143.77 +/- 15.49</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Elderly (&gt;65 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>61.1(52.0-72.9)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 uears old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Environmental enteric dysfunction</patient_information>
      <comment>n=247</comment>
      <references>
        <reference>
          <reference_text>Semba RD, Shardell M, Trehan I, Moaddel R, Maleta KM, Ordiz MI, Kraemer K, Khadeer M, Ferrucci L, Manary MJ: Metabolic alterations in children with environmental enteric dysfunction. Sci Rep. 2016 Jun 13;6:28009. doi: 10.1038/srep28009.</reference_text>
          <pubmed_id>27294788</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>50.5 (15.4) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Down syndrome pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>54.1 (20.7) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>15.3 (10.4-20.2)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hypothyroidism</patient_information>
      <references>
        <reference>
          <reference_text>Sjoberg S, Eriksson M, Nordin C: L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol. 1998 Nov;139(5):493-7.</reference_text>
          <pubmed_id>9849813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>14.2 +/-12.5</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Epilepsy</patient_information>
      <references>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>13.0 +/- 10.6</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Epilepsy </patient_information>
      <references>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>12.3 +/- 9.3 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Epilepsy </patient_information>
      <references>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>9.4 +/- 4.9 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Epilepsy</patient_information>
      <references>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>8.05 +/- 3.03</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Epilepsy </patient_information>
      <references>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>27.18 +/- 4.8</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>13.0 +/- 4.1</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Leukemia</patient_information>
      <references>
        <reference>
          <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
          <pubmed_id>15911239</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>12.6 +/- 3.3</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Leukemia</patient_information>
      <comment>Acute Lymphoblastic Leukemia (ALL) with Central Nervous System (CNS) disease
</comment>
      <references>
        <reference>
          <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
          <pubmed_id>15911239</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>15.3 +/- 4.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>hypothyroidism</patient_information>
      <references>
        <reference>
          <reference_text>Sjoberg S, Eriksson M, Nordin C: L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol. 1998 Nov;139(5):493-7.</reference_text>
          <pubmed_id>9849813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>15.3 +/- 4.9 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Hypothyroidism</patient_information>
      <references>
        <reference>
          <reference_text>Sjoberg S, Eriksson M, Nordin C: L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol. 1998 Nov;139(5):493-7.</reference_text>
          <pubmed_id>9849813</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>7.8 +/- 1.38</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <references>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal Cancer</patient_information>
      <references>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Autism</patient_information>
      <references>
        <reference>
          <reference_text>De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013.</reference_text>
          <pubmed_id>24130822</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>CCD</patient_information>
      <references>
        <reference>
          <reference_text>Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P: Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009 Jul 28;4(7):e6386. doi: 10.1371/journal.pone.0006386.</reference_text>
          <pubmed_id>19636438</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ileal Crohn's disease</patient_information>
      <references>
        <reference>
          <reference_text>Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P: Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009 Jul 28;4(7):e6386. doi: 10.1371/journal.pone.0006386.</reference_text>
          <pubmed_id>19636438</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (6 - 18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Crohns disease</patient_information>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (6 - 18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (6 - 18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Crohns disease</patient_information>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (6 - 18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Children (6 - 18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Unclassified IBD </patient_information>
      <references>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Myalgic encephalomyelitis/chronic fatigue syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Christopher W. ArmstrongNeil R. McGregorDonald P. LewisHenry L. ButtPaul R. Gooley. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics.  January 2017, 13:8: https://link.springer.com/article/10.1007/s11306-016-1145-z</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Irritable bowel syndrome</patient_information>
      <comment>2D NMR on fecal extracts</comment>
      <references>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <comment>2D NMR on fecal extracts</comment>
      <references>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Irritable Bowel Syndrome</patient_information>
      <references>
        <reference>
          <reference_text>Hong YS, Hong KS, Park MH, Ahn YT, Lee JH, Huh CS, Lee J, Kim IK, Hwang GS, Kim JS: Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J Clin Gastroenterol. 2011 May-Jun;45(5):415-25. doi: 10.1097/MCG.0b013e318207f76c.</reference_text>
          <pubmed_id>21494186</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Crohns disease</patient_information>
      <references>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <references>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Attachment loss </patient_information>
      <comment/>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Missing teeth</patient_information>
      <comment/>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Periodontal Probing Depth</patient_information>
      <comment/>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>21.64 +/- 9.24</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Oral cancer</patient_information>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Breast cancer</patient_information>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Pancreatic cancer</patient_information>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Periodontal diseases</patient_information>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>25.82 +/- 9.25</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Frontotemporal lobe dementia</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>25.05 +/- 8.02</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Lewy body disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Bladder cancer</patient_information>
      <comment>Significantly decreased in bladder cancer group</comment>
      <references>
        <reference>
          <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
          <pubmed_id>28157703</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>35.150-369</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Fumaric aciduria</patient_information>
      <references>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>16.005 +/- 10.562</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>10.5 +/- 1.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease </patient_information>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>10.72 +/- 4.63 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Cachexia</patient_information>
      <references>
        <reference>
          <reference_text>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810.  Epub 2008 Oct 25.</reference_text>
          <pubmed_id>18953024</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <references>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>20.2606 +/- 11.9167</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By DI-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>16.2462 +/- 14.3236</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Gastroesophageal reflux disease</patient_information>
      <comment>By DI-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Epilepsy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.</reference_text>
          <pubmed_id>14992292</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cady EB, Lorek A, Penrice J, Reynolds EO, Iles RA, Burns SP, Coutts GA, Cowan FM: Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med. 1994 Dec;32(6):764-7.</reference_text>
          <pubmed_id>7869898</pubmed_id>
        </reference>
        <reference>
          <reference_text>Perosa SR, Porcionatto MA, Cukiert A, Martins JR, Amado D, Nader HB, Cavalheiro EA, Leite JP, Naffah-Mazzacoratti MG: Extracellular matrix components are altered in the hippocampus, cortex, and cerebrospinal fluid of patients with mesial temporal lobe epilepsy. Epilepsia. 2002;43 Suppl 5:159-61.</reference_text>
          <pubmed_id>12121313</pubmed_id>
        </reference>
        <reference>
          <reference_text>Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH: The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Neurology. 1999 Oct 22;53(7):1518-22.</reference_text>
          <pubmed_id>10534261</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rating D, Siemes H, Loscher W: Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis. J Neurol. 1983;230(4):217-25.</reference_text>
          <pubmed_id>6198481</pubmed_id>
        </reference>
        <reference>
          <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
          <pubmed_id>1705463</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
          <pubmed_id>7126379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Czarnecka J, Cieslak M, Michal K: Application of solid phase extraction and high-performance liquid chromatography to qualitative and quantitative analysis of nucleotides and nucleosides in human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):85-90.</reference_text>
          <pubmed_id>15993662</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shaywitz BA, Cohen DJ, Bowers MB: Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology. 1975 Jan;25(1):72-9.</reference_text>
          <pubmed_id>803305</pubmed_id>
        </reference>
        <reference>
          <reference_text>Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92.</reference_text>
          <pubmed_id>10577274</pubmed_id>
        </reference>
        <reference>
          <reference_text>Romigi A, Bari M, Placidi F, Marciani MG, Malaponti M, Torelli F, Izzi F, Prosperetti C, Zannino S, Corte F, Chiaramonte C, Maccarrone M: Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. Epilepsia. 2010 May;51(5):768-72. doi: 10.1111/j.1528-1167.2009.02334.x. Epub 2009 Oct 8.</reference_text>
          <pubmed_id>19817812</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hirai K, Seki T: Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children. Neuropeptides. 2000 Feb;34(1):18-24.</reference_text>
          <pubmed_id>10688964</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
          <pubmed_id>436860</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Myocardial infarction</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR: The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr. 1976 Sep;29(9):997-1006.</reference_text>
          <pubmed_id>822705</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC: Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol. 2007 May 22;49(20):1993-2000. Epub 2007 May 4.</reference_text>
          <pubmed_id>17512353</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yada T, Kaji S, Akasaka T, Mochizuki S, Ogasawara Y, Tanemoto K, Yoshida K, Kajiya F: Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clin Hemorheol Microcirc. 2007;37(3):269-76.</reference_text>
          <pubmed_id>17726257</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Viral infection</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR: The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr. 1976 Sep;29(9):997-1006.</reference_text>
          <pubmed_id>822705</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Schizophrenia</name>
      <omim_id>181500</omim_id>
      <references>
        <reference>
          <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
          <pubmed_id>115032</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
          <pubmed_id>7126379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
        <reference>
          <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
          <pubmed_id>17276036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
          <pubmed_id>11877547</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
          <pubmed_id>12796220</pubmed_id>
        </reference>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
          <pubmed_id>20814316</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
          <pubmed_id>24713860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
          <pubmed_id>23823132</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
          <pubmed_id>2415198</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
          <pubmed_id>1694425</pubmed_id>
        </reference>
        <reference>
          <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
          <pubmed_id>7711000</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
          <pubmed_id>19390223</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
          <pubmed_id>21483431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
          <pubmed_id>3741918</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
          <pubmed_id>11979513</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
          <pubmed_id>20206656</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
          <pubmed_id>436860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19401681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
          <pubmed_id>6184954</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
          <pubmed_id>26952797</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
        <reference>
          <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
          <pubmed_id>24789758</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
          <pubmed_id>22944140</pubmed_id>
        </reference>
        <reference>
          <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
          <pubmed_id>22892715</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
          <pubmed_id>17440431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
          <pubmed_id>25729574</pubmed_id>
        </reference>
        <reference>
          <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
          <pubmed_id>22257447</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Alzheimer's disease</name>
      <omim_id>104300</omim_id>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
        <reference>
          <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
          <pubmed_id>11959400</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
          <pubmed_id>8595727</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
          <pubmed_id>15361288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
          <pubmed_id>15465626</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
          <pubmed_id>10494443</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
          <pubmed_id>11255442</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
          <pubmed_id>12498967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
          <pubmed_id>16227558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
          <pubmed_id>9720975</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
          <pubmed_id>12111441</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
          <pubmed_id>16244393</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
          <pubmed_id>8356878</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
          <pubmed_id>12391605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
          <pubmed_id>8478958</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
          <pubmed_id>21292280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
          <pubmed_id>20858978</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
          <pubmed_id>21474939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
          <pubmed_id>20523031</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
          <pubmed_id>11314776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
          <pubmed_id>1716470</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Colorectal cancer</name>
      <omim_id>114500</omim_id>
      <references>
        <reference>
          <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
          <pubmed_id>7482520</pubmed_id>
        </reference>
        <reference>
          <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
          <pubmed_id>19006102</pubmed_id>
        </reference>
        <reference>
          <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
          <pubmed_id>23940645</pubmed_id>
        </reference>
        <reference>
          <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
          <pubmed_id>24424155</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
          <pubmed_id>20156336</pubmed_id>
        </reference>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
          <pubmed_id>22148915</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
          <pubmed_id>21773981</pubmed_id>
        </reference>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
          <pubmed_id>28587349</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Early preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pregnancy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
          <pubmed_id>3252730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
          <pubmed_id>663967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
          <pubmed_id>12833386</pubmed_id>
        </reference>
        <reference>
          <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
          <pubmed_id>2994907</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
          <pubmed_id>17704099</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
          <pubmed_id>12698507</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
          <pubmed_id>17061063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
          <pubmed_id>16925883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
          <pubmed_id>22420377</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18059417</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
        <reference>
          <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Late-onset preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Fumarase deficiency</name>
      <omim_id>606812</omim_id>
      <references>
        <reference>
          <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
          <pubmed_id>26078636</pubmed_id>
        </reference>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tregoning S, Salter W, Thorburn DR, Durkie M, Panayi M, Wu JY, Easterbrook A, Coman DJ: Fumarase deficiency in dichorionic diamniotic twins. Twin Res Hum Genet. 2013 Dec;16(6):1117-20. doi: 10.1017/thg.2013.72. Epub 2013 Nov 4.</reference_text>
          <pubmed_id>24182348</pubmed_id>
        </reference>
        <reference>
          <reference_text>Whelan DT, Hill RE, McClorry S: Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983 Aug 31;132(3):301-8.</reference_text>
          <pubmed_id>6616883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Maradin M, Fumic K, Hansikova H, Tesarova M, Wenchich L, Dorner S, Sarnavka V, Zeman J, Baric I: Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis. 2006 Oct;29(5):683. Epub 2006 Aug 5.</reference_text>
          <pubmed_id>16972175</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Tyrosinemia</name>
      <omim_id>276700</omim_id>
      <references>
        <reference>
          <reference_text>Cyr D, Giguere R, Villain G, Lemieux B, Drouin R: A GC/MS validated method for the nanomolar range determination of succinylacetone in amniotic fluid and plasma: an analytical tool for tyrosinemia type I. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 17;832(1):24-9. Epub 2006 Jan 18.</reference_text>
          <pubmed_id>16414314</pubmed_id>
        </reference>
        <reference>
          <reference_text>Swarna M, Jyothy A, Usha Rani P, Reddy PP: Amino acid disorders in mental retardation: a two-decade study from Andhra Pradesh. Biochem Genet. 2004 Apr;42(3-4):85-98.</reference_text>
          <pubmed_id>15168722</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Tyrosinemia I</name>
      <omim_id>276700</omim_id>
      <references>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nakamura K, Matsumoto S, Mitsubuchi H, Endo F: Diagnosis and treatment of hereditary tyrosinemia in Japan. Pediatr Int. 2015;57(1):37-40. doi: 10.1111/ped.12550.</reference_text>
          <pubmed_id>25443793</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gissen P, Preece MA, Willshaw HA, McKiernan PJ: Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC. J Inherit Metab Dis. 2003;26(1):13-6.</reference_text>
          <pubmed_id>12872835</pubmed_id>
        </reference>
        <reference>
          <reference_text>Han LS, Ye J, Qiu WJ, Zhang HW, Wang Y, Ji WJ, Gao XL, Li XY, Jin J, Gu XF: [Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1]. Zhonghua Er Ke Za Zhi. 2012 Feb;50(2):126-30.</reference_text>
          <pubmed_id>22455637</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases. 2nd ed. Berlin, Germany, Springer, 2003</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hypermethioninemia</name>
      <omim_id>613752</omim_id>
      <references>
        <reference>
          <reference_text>Labrune P, Perignon JL, Rault M, Brunet C, Lutun H, Charpentier C, Saudubray JM, Odievre M: Familial hypermethioninemia partially responsive to dietary restriction. J Pediatr. 1990 Aug;117(2 Pt 1):220-6.</reference_text>
          <pubmed_id>2380820</pubmed_id>
        </reference>
        <reference>
          <reference_text>Baric I, Staufner C, Augoustides-Savvopoulou P, Chien YH, Dobbelaere D, Grunert SC, Opladen T, Petkovic Ramadza D, Rakic B, Wedell A, Blom HJ: Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders. J Inherit Metab Dis. 2017 Jan;40(1):5-20. doi: 10.1007/s10545-016-9972-7. Epub 2016 Sep 26.</reference_text>
          <pubmed_id>27671891</pubmed_id>
        </reference>
        <reference>
          <reference_text>Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH: S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4234-9. Epub 2004 Mar 15.</reference_text>
          <pubmed_id>15024124</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hawkinsinuria</name>
      <omim_id>140350</omim_id>
      <references>
        <reference>
          <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
          <pubmed_id>11978597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Thodi G, Schulpis KH, Dotsikas Y, Pavlides C, Molou E, Chatzidaki M, Triantafylli O, Loukas YL: Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment. J Pediatr Endocrinol Metab. 2016 Jan;29(1):15-20. doi: 10.1515/jpem-2015-0132.</reference_text>
          <pubmed_id>26226126</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lehnert W, Stogmann W, Engelke U, Wevers RA, van den Berg GB: Long-term follow up of a new case of hawkinsinuria. Eur J Pediatr. 1999 Jul;158(7):578-82.</reference_text>
          <pubmed_id>10412819</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Obesity</name>
      <omim_id>601665</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
          <pubmed_id>16253646</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
          <pubmed_id>2401584</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
          <pubmed_id>17264178</pubmed_id>
        </reference>
        <reference>
          <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
          <pubmed_id>1783639</pubmed_id>
        </reference>
        <reference>
          <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
          <pubmed_id>26505825</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
          <pubmed_id>17408529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
          <pubmed_id>18997681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
          <pubmed_id>24740590</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
          <pubmed_id>23108202</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
          <pubmed_id>26910390</pubmed_id>
        </reference>
        <reference>
          <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Citrullinemia type II, neonatal-onset</name>
      <omim_id>605814</omim_id>
      <references>
        <reference>
          <reference_text>Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, Iinuma K, Saheki T: Neonatal presentation of adult-onset type II citrullinemia. Hum Genet. 2001 Feb;108(2):87-90.</reference_text>
          <pubmed_id>11281457</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Hypothyroidism</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Sjoberg S, Eriksson M, Nordin C: L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol. 1998 Nov;139(5):493-7.</reference_text>
          <pubmed_id>9849813</pubmed_id>
        </reference>
        <reference>
          <reference_text>Verhelst J, Berwaerts J, Marescau B, Abs R, Neels H, Mahler C, De Deyn PP: Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. Metabolism. 1997 Sep;46(9):1063-7.</reference_text>
          <pubmed_id>9284897</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chopra IJ, Santini F, Hurd RE, Chua Teco GN: A radioimmunoassay for measurement of thyroxine sulfate. J Clin Endocrinol Metab. 1993 Jan;76(1):145-50.</reference_text>
          <pubmed_id>8421080</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hommel E, Faber J, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Urinary excretion of unconjugated and conjugated 3,5-diiodothyronine. Horm Metab Res. 1985 Feb;17(2):90-2.</reference_text>
          <pubmed_id>3988241</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yoshida K, Sakurada T, Kaise N, Yamamoto M, Kaise K, Saito S, Yoshinaga K: Measurement of triiodothyronine in urine. Tohoku J Exp Med. 1980 Dec;132(4):389-95.</reference_text>
          <pubmed_id>7256725</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Leukemia</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia. Cancer Lett. 1998 Jan 9;122(1-2):1-8.</reference_text>
          <pubmed_id>9464484</pubmed_id>
        </reference>
        <reference>
          <reference_text>Curtius HC, Wolfensberger M, Redweik U, Leimbacher W, Maibach RA, Isler W: Mass fragmentography of 5-hydroxytryptophol and 5-methoxytryptophol in human cerebrospinal fluid. J Chromatogr. 1975 Oct 29;112:523-31.</reference_text>
          <pubmed_id>1184685</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
          <pubmed_id>15911239</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
          <pubmed_id>7482520</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silvennoinen R, Malminiemi K, Malminiemi O, Seppala E, Vilpo J: Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses. Pharmacol Toxicol. 2000 Nov;87(5):223-8.</reference_text>
          <pubmed_id>11129502</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Irritable bowel syndrome</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Bearcroft CP, Perrett D, Farthing MJ: Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998 Jan;42(1):42-6.</reference_text>
          <pubmed_id>9505884</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
          <pubmed_id>8723414</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17.</reference_text>
          <pubmed_id>21330412</pubmed_id>
        </reference>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hong YS, Hong KS, Park MH, Ahn YT, Lee JH, Huh CS, Lee J, Kim IK, Hwang GS, Kim JS: Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J Clin Gastroenterol. 2011 May-Jun;45(5):415-25. doi: 10.1097/MCG.0b013e318207f76c.</reference_text>
          <pubmed_id>21494186</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J: Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.</reference_text>
          <pubmed_id>27662586</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Ulcerative colitis</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
          <pubmed_id>21059682</pubmed_id>
        </reference>
        <reference>
          <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
          <pubmed_id>1740537</pubmed_id>
        </reference>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
        <reference>
          <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
          <pubmed_id>17314143</pubmed_id>
        </reference>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
          <pubmed_id>23516449</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
          <pubmed_id>24811995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
          <pubmed_id>26806034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
          <pubmed_id>26848182</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Autism</name>
      <omim_id>209850</omim_id>
      <references>
        <reference>
          <reference_text>Shaw W: Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci. 2010 Jun;13(3):135-43. doi: 10.1179/147683010X12611460763968.</reference_text>
          <pubmed_id>20423563</pubmed_id>
        </reference>
        <reference>
          <reference_text>Narayan M, Srinath S, Anderson GM, Meundi DB: Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry. 1993 Apr 15-May 1;33(8-9):630-5.</reference_text>
          <pubmed_id>7687150</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jaeken J, Van den Berghe G: An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet. 1984 Nov 10;2(8411):1058-61.</reference_text>
          <pubmed_id>6150139</pubmed_id>
        </reference>
        <reference>
          <reference_text>James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004 Dec;80(6):1611-7.</reference_text>
          <pubmed_id>15585776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Anderson GM, Ross DL, Klykylo W, Feibel FC, Cohen DJ: Cerebrospinal fluid indoleacetic acid in autistic subjects. J Autism Dev Disord. 1988 Jun;18(2):259-62.</reference_text>
          <pubmed_id>3410814</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T: Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann Neurol. 2002 Sep;52(3):372-4.</reference_text>
          <pubmed_id>12205654</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013.</reference_text>
          <pubmed_id>24130822</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Crohn's disease</name>
      <omim_id>266600</omim_id>
      <references>
        <reference>
          <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
          <pubmed_id>16440420</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
          <pubmed_id>11418788</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
          <pubmed_id>8723414</pubmed_id>
        </reference>
        <reference>
          <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19491857</pubmed_id>
        </reference>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
          <pubmed_id>23516449</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
          <pubmed_id>24811995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
          <pubmed_id>26806034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
          <pubmed_id>26848182</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Perillyl alcohol administration for cancer treatment</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Byun JA, Lee SH, Jung BH, Choi MH, Moon MH, Chung BC: Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2008 Jan;22(1):73-80.</reference_text>
          <pubmed_id>17668437</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW: Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin Biochem. 2005 Jan;38(1):24-30.</reference_text>
          <pubmed_id>15607313</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR, Kuller LH: Estrogen metabolites and the risk of breast cancer in older women. Epidemiology. 2003 Nov;14(6):740-4.</reference_text>
          <pubmed_id>14569192</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang Z, Chen H, Chan KK, Budd T, Ganapathi R: Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma. J Chromatogr B Biomed Sci Appl. 1999 May 14;728(1):85-95.</reference_text>
          <pubmed_id>10379660</pubmed_id>
        </reference>
        <reference>
          <reference_text>Grace PB, Mistry NS, Carter MH, Leathem AJ, Teale P: High throughput quantification of phytoestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):138-46. Epub  2007 Mar 18.</reference_text>
          <pubmed_id>17403619</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec  22.</reference_text>
          <pubmed_id>22284503</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lv W, Yang T: Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem. 2012 Jan;45(1-2):127-33. doi: 10.1016/j.clinbiochem.2011.10.011. Epub 2011 Oct 26.</reference_text>
          <pubmed_id>22061338</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
          <pubmed_id>19783829</pubmed_id>
        </reference>
        <reference>
          <reference_text>Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC: Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta. 2009 Feb;400(1-2):63-9. doi: 10.1016/j.cca.2008.10.014. Epub 2008 Oct 30.</reference_text>
          <pubmed_id>19010317</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pancreatic cancer</name>
      <omim_id>260350</omim_id>
      <references>
        <reference>
          <reference_text>Loser C, Folsch UR, Paprotny C, Creutzfeldt W: Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. Pancreas. 1990 Mar;5(2):119-27.</reference_text>
          <pubmed_id>2315288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang L, Jin H, Guo X, Yang Z, Zhao L, Tang S, Mo P, Wu K, Nie Y, Pan Y, Fan D: Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem. 2012 Sep;45(13-14):1064-9. doi: 10.1016/j.clinbiochem.2012.05.012.  Epub 2012 May 19.</reference_text>
          <pubmed_id>22613268</pubmed_id>
        </reference>
        <reference>
          <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
          <pubmed_id>21505807</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xie G, Lu L, Qiu Y, Ni Q, Zhang W, Gao YT, Risch HA, Yu H, Jia W: Plasma metabolite biomarkers for the detection of pancreatic cancer. J Proteome Res. 2015 Feb 6;14(2):1195-202. doi: 10.1021/pr501135f. Epub 2014 Dec  8.</reference_text>
          <pubmed_id>25429707</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Periodontal disease</name>
      <omim_id>170650</omim_id>
      <references>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Frontotemporal dementia</name>
      <omim_id>600274</omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Lewy body disease</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Attachment loss</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Missing teeth</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Periodontal Probing Depth</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr  26.</reference_text>
          <pubmed_id>31026179</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Cachexia</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810.  Epub 2008 Oct 25.</reference_text>
          <pubmed_id>18953024</pubmed_id>
        </reference>
        <reference>
          <reference_text>Doehner W, Rauchhaus M, Florea VG, Sharma R, Bolger AP, Davos CH, Coats AJ, Anker SD: Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance. Am Heart J. 2001 May;141(5):792-9.</reference_text>
          <pubmed_id>11320368</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
  </diseases>
  <kegg_id>C00082</kegg_id>
  <drugbank_id>DB00135</drugbank_id>
  <foodb_id>FDB000446</foodb_id>
  <chemspider_id>5833</chemspider_id>
  <pubchem_compound_id>6057</pubchem_compound_id>
  <pdb_id/>
  <chebi_id>17895</chebi_id>
  <biocyc_id>TYR</biocyc_id>
  <knapsack_id>C00001397</knapsack_id>
  <wikipedia_id>Tyrosine</wikipedia_id>
  <phenol_explorer_compound_id/>
  <bigg_id>33785</bigg_id>
  <metlin_id>34</metlin_id>
  <vmh_id>TYR_L</vmh_id>
  <fbonto_id/>
  <synthesis_reference>Enei, Hitoshi; Matsui, Hiroshi; Yamashita, Koichi; Okumura, Shinji; Yamada, Hideaki. Microbiological synthesis of L-tyrosine and 3,4-dihydroxyphenyl-L-alanine. I. Distribution of tyrosine phenol lyase in microorganisms. Agricultural and Biological Chemist  1972, 36:11, 1861-1868, DOI: 10.1080/00021369.1972.10860505</synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
      <pubmed_id>12101068</pubmed_id>
    </reference>
    <reference>
      <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
      <pubmed_id>15911239</pubmed_id>
    </reference>
    <reference>
      <reference_text>Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.</reference_text>
      <pubmed_id>12297216</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.</reference_text>
      <pubmed_id>14992292</pubmed_id>
    </reference>
    <reference>
      <reference_text>Flamen P, Bernheim N, Deron P, Caveliers V, Chavatte K, Franken PR, Bossuyt A: Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas. Eur J Nucl Med. 1998 Feb;25(2):177-81.</reference_text>
      <pubmed_id>9473267</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sjoberg S, Eriksson M, Nordin C: L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur J Endocrinol. 1998 Nov;139(5):493-7.</reference_text>
      <pubmed_id>9849813</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ishiwata K, Tsukada H, Kubota K, Nariai T, Harada N, Kawamura K, Kimura Y, Oda K, Iwata R, Ishii K: Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography. Nucl Med Biol. 2005 Apr;32(3):253-62.</reference_text>
      <pubmed_id>15820760</pubmed_id>
    </reference>
    <reference>
      <reference_text>Wannemacher RW Jr, Klainer AS, Dinterman RE, Beisel WR: The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection. Am J Clin Nutr. 1976 Sep;29(9):997-1006.</reference_text>
      <pubmed_id>822705</pubmed_id>
    </reference>
    <reference>
      <reference_text>Eklundh T, Eriksson M, Sjoberg S, Nordin C: Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. J Psychiatr Res. 1996 May-Jun;30(3):201-8.</reference_text>
      <pubmed_id>8884658</pubmed_id>
    </reference>
    <reference>
      <reference_text>Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.</reference_text>
      <pubmed_id>12097436</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75.</reference_text>
      <pubmed_id>6696735</pubmed_id>
    </reference>
    <reference>
      <reference_text>Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.</reference_text>
      <pubmed_id>12834252</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.</reference_text>
      <pubmed_id>6198473</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
      <pubmed_id>19212411</pubmed_id>
    </reference>
    <reference>
      <reference_text>Molnar GA, Wagner Z, Marko L, Ko Szegi T, Mohas M, Kocsis B, Matus Z, Wagner L, Tamasko M, Mazak I, Laczy B, Nagy J, Wittmann I: Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production. Kidney Int. 2005 Nov;68(5):2281-7.</reference_text>
      <pubmed_id>16221230</pubmed_id>
    </reference>
    <reference>
      <reference_text>Molnar GA, Nemes V, Biro Z, Ludany A, Wagner Z, Wittmann I: Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase. Free Radic Res. 2005 Dec;39(12):1359-66.</reference_text>
      <pubmed_id>16298866</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hoffhines AJ, Damoc E, Bridges KG, Leary JA, Moore KL: Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody. J Biol Chem. 2006 Dec 8;281(49):37877-87. Epub 2006 Oct 17.</reference_text>
      <pubmed_id>17046811</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
      <pubmed_id>32033212</pubmed_id>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00087</protein_accession>
      <name>Tyrosinase</name>
      <uniprot_id>P14679</uniprot_id>
      <gene_name>TYR</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00273</protein_accession>
      <name>Tyrosine 3-monooxygenase</name>
      <uniprot_id>P07101</uniprot_id>
      <gene_name>TH</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00276</protein_accession>
      <name>Thyroid peroxidase</name>
      <uniprot_id>P07202</uniprot_id>
      <gene_name>TPO</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00277</protein_accession>
      <name>Tyrosine aminotransferase</name>
      <uniprot_id>P17735</uniprot_id>
      <gene_name>TAT</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00278</protein_accession>
      <name>Aromatic-L-amino-acid decarboxylase</name>
      <uniprot_id>P20711</uniprot_id>
      <gene_name>DDC</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00280</protein_accession>
      <name>Phenylalanine-4-hydroxylase</name>
      <uniprot_id>P00439</uniprot_id>
      <gene_name>PAH</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00283</protein_accession>
      <name>Aspartate aminotransferase, cytoplasmic</name>
      <uniprot_id>P17174</uniprot_id>
      <gene_name>GOT1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00284</protein_accession>
      <name>Aspartate aminotransferase, mitochondrial</name>
      <uniprot_id>P00505</uniprot_id>
      <gene_name>GOT2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00606</protein_accession>
      <name>Tyrosine--tRNA ligase, cytoplasmic</name>
      <uniprot_id>P54577</uniprot_id>
      <gene_name>YARS</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00619</protein_accession>
      <name>Tyrosine--tRNA ligase, mitochondrial</name>
      <uniprot_id>Q9Y2Z4</uniprot_id>
      <gene_name>YARS2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01112</protein_accession>
      <name>Monocarboxylate transporter 8</name>
      <uniprot_id>P36021</uniprot_id>
      <gene_name>SLC16A2</gene_name>
      <protein_type>Transporter</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01450</protein_accession>
      <name>Basic fibroblast growth factor receptor 1</name>
      <uniprot_id>P11362</uniprot_id>
      <gene_name>FGFR1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01456</protein_accession>
      <name>Epidermal growth factor receptor</name>
      <uniprot_id>P00533</uniprot_id>
      <gene_name>EGFR</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP05340</protein_accession>
      <name>Monocarboxylate transporter 10</name>
      <uniprot_id>Q8TF71</uniprot_id>
      <gene_name>SLC16A10</gene_name>
      <protein_type>Transporter</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08281</protein_accession>
      <name>L-amino-acid oxidase</name>
      <uniprot_id>Q96RQ9</uniprot_id>
      <gene_name>IL4I1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08295</protein_accession>
      <name>Iodotyrosine dehalogenase 1</name>
      <uniprot_id>Q6PHW0</uniprot_id>
      <gene_name>IYD</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08831</protein_accession>
      <name>Tubulin--tyrosine ligase</name>
      <uniprot_id>Q8NG68</uniprot_id>
      <gene_name>TTL</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
  </protein_associations>
</metabolite>
</hmdb>